Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of Ilaprazole 10 mg to prevent NSAID-associated peptic ulcers; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peptic Ulcer

Drugs mentioned

• Ilaprazole 10 mg (ilaprazole)

Snippet

Sponsor: Il-Yang Pharm. Co., Ltd. | Conditions: Peptic Ulcer | Phase 3 | Status: RECRUITING